Skip to content

Investigating the effect of piroxicam mesotherapy in the treatment of tennis elbow

Investigation of the effect of mesotherapy with piroxicam in the treatment of tennis elbow in comparison with oral medical therapy in terms of improving pain and function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230515058198N1
Enrollment
36
Registered
2023-07-24
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral epicondylitis. Lateral epicondylitis

Interventions

Intervention 1: Intervention group: Subcutaneous injection (mesotherapy) of 1 ml piroxicam 20 mg/ml with 1 ml lidocaine 2% is applied in the acupuncture points Lu6, Li10, Li11, Li12 and the maximal te

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Completing and signing the consent form Clinical diagnosis of tennis elbow in the form of pain in the external epicondyle region of the humerus bone by applying local pressure and wrist extension against resistance At least one month has passed since the onset of the patient's symptoms Having a pain Visual Analogue Scale of at least 4

Exclusion criteria

Exclusion criteria: Any signs and symptoms of effusion, inflammation, redness and warmth of the affected area Having uncontrolled diabetes mellitus Having rheumatic and collagen vascular disorders Suffering from active cervical radiculopathy, neuropathy or myopathy simultaneously in the upper limbs Having any type of serious systemic and local infection History of surgery, trauma, fracture and dislocation in the elbow joint on the affected side, severe deformity in the upper limb Individuals with bleeding disorders and/or taking anticoagulants History of allergies and allergic reactions to the medications used History of significant liver, kidney, gastrointestinal, cerebral and cardiopulmonary disorders, history of gastrointestinal bleeding History of injections in or around the affected elbow joint in the last three months History of elbow and upper limb physiotherapy in the last one month Taking non-steroidal anti-inflammatory drugs (NSAIDs) in the last 48 hours and steroidal anti-inflammatory drugs in the last two weeks Pregnant women and lactating women Individuals with cancer Inability to communicate and complete questionnaires

Design outcomes

Primary

MeasureTime frame
Upper limb pain. Timepoint: Before intervention, two weeks and four weeks later. Method of measurement: Visual Analogue Scale (VAS); Patient-Rated Tennis Elbow Evaluation (PRTEE).

Secondary

MeasureTime frame
Function of patient. Timepoint: Before intervention, two weeks and four weeks later. Method of measurement: Patient-Rated Tennis Elbow Evaluation (PRTEE).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Zare

Shiraz University of Medical Sciences

niloofarzare@sums.ac.ir+98 71 3231 5768

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026